Gynaecological cancers in Umbria (Italy): Trends of incidence, mortality and survival, 1978-1998

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 115, Issue 1, 2004, Pages 59-65

  Minelli, Liliana ^a   Stracci, Fabrizio ^b   Prandini, Stefania ^b   Moffa, Igino Fusco ^b   La Rosa, Francesco ^a,b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Umbrian Pop Based Cancer Registry   (Italy)

Author keywords

Cancer registry; Gynaecological tumours; Incidence; Mortality; Survival

Indexed keywords

ADULT; AGED; CALCULATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; HUMAN; ITALY; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER;

EID: 3042545923     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2003.11.026     Document Type: Article

References (40)

1. Levi F., Lucchini F., Negri E., Boyle P., La Vecchia C. Cancer mortality in Europe, 1990-1994a, and an overview of trends from 1955 to 1994. Eur. J. Cancer. 35:1999;1477-1516
2. Coleman RJ, Estève J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. IARC Scientific Publication No. 121. Lyon: IARC; 1993.
3. Parazzini F., La Vecchia C., Bocciolone L., Franceschi S. The epidemiology of endometrial cancer. Gynecol. Oncol. 41:1991;1-16
4. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int. J. Cancer. 80:1999;827-884
5. Pisani P., Parkin D.M., Bray F., Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1999. Int. J. Cancer. 83:1999;18-29
6. Parkin D.M., Pisani P., Ferlay J. Global cancer statics. CA Cancer J. Clin. 49:1999;33-64
7. Shanta V., Krishnamurthi S., Gajalakshmi C.K., Swaminathan R., Ravichandran K. Epidemiology of cancer of the cervix: global and national perspective. J. Indian Med. Assoc. 98(2):2000;49-52
8. Cuzick J., Boyle P. Trends in cervix cancer mortality. Cancer Surv. 7:1988;417-439
9. Sasiani P., Cuzick J., Farmery E. Accelerated decline in cervical cancer mortality in England and Wales (letter). Lancet. 346:1995;1566-1567
10. Gatta G., Capocaccia R., Coleman M.P. Toward a comparison of survival in American and European cancer patients. Cancer. 89(4):2000;893-900
11. Welch H.G., Schwartz L.M., Woloshin S. Are increasing 5-year survival rates evidence of success against cancer? JAMA. 22:2000;2975-2978
12. WHO: Manual of the International Statistical Classification of Disease, Injuries and Causes of Death, Based on the Recommendations of the Ninth Revision Conference, 1975. Geneva: WHO; 1977.
13. Mastrandrea V, Vitali R, La Rosa F, Petrinelli AM. Incidenza e mortalità per tumori maligni in Umbria (1978-1982). Perugia: Regione dell'Umbria; 1988.
14. La Rosa F, Stracci F, Minelli L, Mastrandrea V. Incidenza, prevalenza e mortalità per tumori maligni in Umbria, 1978-1998. Perugia: Regione dell'Umbria; 2002.
15. Waterhouse J, Muir C, Shanmugaratnam K, Powell J. Cancer incidence in five continents, vol. IV. Lyon: WHO; 1982.
16. La Rosa F., Minelli L., Petrinelli A.M., Angeli G., Epifani A.C., Mastrandrea V. Cancer Survival From Incident Cases of a Population-Based Study in the Umbria Region, Italy. Eur. J. Cancer. 33:1997;2241-2245
17. Mastrandrea V., La Rosa F. RTUP Working Group: Umbrian population cancer registry. Organization and functioning. Quad. Oncol. 6:1996;295-297
18. Parkin DM, Muir CS. Cancer incidence in five continents, vol. VI. IARC. Sci. Publ. No. 120. Lyon: IARC; 1992.
19. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, editors. Cancer incidence in five continents, vol. VII. IARC Scientific Publication No. 143. Lyon: IARC; 1997.
20. Kim H.J., Fay M.P., Feuer E.J., Midthune D.N. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 19:2000;335-351
21. Estève J., Benhamou E., Croasdale M., Raymond L. Relative survival and the estimation of net survival: elements for further discussion. Stat. Med. 9:1990;529-538
22. Coleman MP, Babb P, Damiecki P, Grosclaude P, Honjo S, Jones J, et al. Cancer survival trends in England and Wales 1971-1995: deprivation and NHS region. Series SMPS No. 61. London: The Stationery Office; 1999.
23. Zanetti R, Gafà L, Pannelli F, et al. Il cancro in Italia. I dati di incidenza dei Registri Tumori. Volume terzo: 1993-1998. Roma: Il Pensiero Scientifico Editore; 2002.
24. Berrino F, Capocaccia R, Esteve J, Gatta G, Hakulineu T, Micheli A, et al. Survival of cancer patients in Europe. The EUROCARE-2 Study. IARC Scientific Publication No. 151. Lyon: IARC; 1999.
25. Rosso S., Casella C., Crocetti E., Ferretti S., Guzzinati S. Sopravvivenza dei casi di tumore in Italia negli anni novanta: i dati dei Registri Tumori. Epidemiol. Prev. 25(3 Suppl.):2001;1-375
26. Gustafsson L., Ponten J., Bergstron R., Adami H.O. International incidence rates of invasive cervical before cytological screening. Int. J. Cancer. 71:1997;159-165
27. Llorca J., Prieto M.D., Delgado-Rodriguez M. Increase in cervical cancer mortality in Spain, 1951-1991. J. Epidemiol. Community Health. 53:1999;408-411
28. Nieminen P., Kallio M., Hakama M. The effect of mass screening in incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet. Gynecol. 85:1995;1017-1021
29. Levi F., Lucchini F., Negri E., Franceschi S., La Vecchia C. Cervical cancer mortality in young women in Europe: patterns and trends. Eur. J. Cancer. 36(17):2000;2266-2271
30. Bergstrom R., Sparen P., Adami H.O. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br. J. Cancer. 81(1):1999;159-166
31. Li H., Jin S., Xu H., Thomas D.B. The decline in the mortality rates of cervical cancer and a plausible explanation in Shandong, China. Int. J. Epidemiol. 29:2000;398-403
32. Faggiano MF, Partanen T, Kogevinas M, Boffeta P, et al. Socioeconomic Differences in Cancer Incidence and Mortality. IARC Scientific Publication No. 138. Lyon: IARC; 1997. p. 65-176.
33. Enégoz F., Blank R.J., Arveux P., Magne V., Ferlay J., Buemi A., et al. Cancer incidence and mortality in France in 1975-95. Eur. J. Cancer Prev. 6:1997;442-466
34. Bjorge T., Engeland A., Hansen S., Tropé G.C. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993. Int. J. Cancer. 71:1997;780-786
35. Walboomers J.M.M., Jacobs M.I., Manos M.M., Bosch F.X., Kummer J.A., Shah K., et al. Human Papillomavirus is a necessary cause of invasive cervical cancer world wide. J. Pathol. 189:1999;12-19
36. Franco E.L., Rohan T.E., Villa L.L. Epidemiologic evidence of Human Papilloma Virus infection as a necessary cause of cervical cancer. J. Natl. Cancer Inst. 91:1999;506-511
37. Beard C.M., Hartmann L.C., Keeney G.L., Crowson C.S., Malkasian G.D., O'Brien P.C., et al. Endometrial cancer in Olmsted County, MN: trends in incidence, risk factors and survival. Ann. Epidemiol. 10:2000;97-105
38. Kelsey B.L.G., Whittemore A.S. Epidemiology and primary prevention of cancer of breast, endometrium. Ann. Epidemiol. 4:1994;89-95
39. Adami H.O., Bergstrom R., Persson I., Sparen P. The incidence of ovarian cancer in Sweden, 1960-1984. Amer. J. Epidemiol. 132:1990;446-452
40. Ewertz M., Kjaer S.K. Ovarian cancer incidence and mortality in Denmark, 1943-1982. Int. J. Cancer. 42:1988;690-696